BackBriaCell Therapeutics Overview

BriaCell Therapeutics Receivables

Track BriaCell Therapeutics's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

BriaCell Therapeutics Receivables History

Loading

BriaCell Therapeutics vs. peers: Receivables Comparison

Loading

BriaCell Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BriaCell Therapeutics (BCT.TO) FAQ

As of the most recent data (July 2026), BCT.TO shows a receivables of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCT.TO's receivables is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether BriaCell Therapeutics is outperforming or lagging.

Tracking BCT.TO's receivables over time shows whether BriaCell Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has BriaCell Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $0) with ownership activity and broader fundamentals.

BriaCell Therapeutics's receivables is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers